Press release
The Ineffective Esophageal Motility Treatment Market to keep pace with the latest technology
Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated. The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such as intake of asthma medications and increasing geriatric population, are also responsible for driving the ineffective esophageal motility treatment market.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/31550
According to the latest report published by PMR, the global ineffective esophageal motility treatment market is projected to expand at a decent CAGR of around 6% during the forecast period (2020–2030).
Key Takeaways from Ineffective Esophageal Motility Treatment Market Study
Significant advantages of ineffective esophageal motility treatment; improving reimbursement scenario for surgical treatment devices; increasing awareness regarding gastric reflux disease; and large patient pool for GERD, dysphagia, achalasia, and burning chest pain are key factors propelling the growth of ineffective esophageal motility treatment market in developing regions.
North America is a prominent region the global ineffective esophageal motility treatment market, while East Asia is expected to offer lucrative growth opportunities, owing to the large population base and higher incidence of GERD and dysphagia.
Higher OTC antacid consumption is poised to drive the growth of the market.
Radiofrequency ablation systems with high level precision and procedural advantages over myotomy are expected to generate significant revenue in the long term.
Increasing adoption of ineffective esophageal motility treatment drugs for quick recovery as compared to device-based treatment marks higher revenue potential.
Raw material procurement issues, drug shortages, and reduced patient visits amidst the COVID-19 pandemic will adversely affect the growth of the ineffective esophageal motility treatment market in the near term.
“Procedural accuracy achieved by treatment devices and affordability of drug-based treatment are anticipated to drive the ineffective esophageal motility treatment market. Additionally, the large patient pool will bring in steady revenue opportunities,” says a PMR analyst.
Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com
Company Profiles:
Johnson & Johnson
Mylan Pharmaceutical
MediGus Ltd.
Torax Medical
Medtronic plc.
AstraZeneca plc.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
GlaxoSmithKline plc.
Bayer AG
Pfizer Inc.
Bausch Health Companies Inc.
LABORIE
Mederi Therapeutics, Inc.
Becton, Dickinson and Company (C. R. Bard, Inc.)
EndoGastric Solutions, Inc
Olympus
Pentax
New Product Launches by Key Players to Strengthen Market Presence
Key manufacturers in the ineffective esophageal motility treatment market are mainly focusing on research & development and introduction new & advanced treatment products. For example, LINX is the new and advanced version of the LINX reflux management device that is used for the transoral incision-less fundoplication process, which is one of the important procedures for the treatment of gastroesophageal reflux disease. The innovation of new & advanced products is a factor boosting the ineffective esophageal motility treatment market. In addition, Olympus Corporation has launched advanced versions of esophagoscopes, which have improved the treatment curve of gastroesophageal reflux disease. Manufacturers are focusing on extended indication list and higher reimbursement to draw demand and increase profitability. Alternatively, a key factor affecting the ineffective esophageal motility treatment market is the entry of generic drug manufacturers. Market leaders are constantly working on strengthening their strategies to gain market share.
For critical insights, request for methodology @ https://www.persistencemarketresearch.com/methodology/31550
What else is in the report?
Persistence Market Research offers a unique perspective and actionable insights on the ineffective esophageal motility treatment market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, on the basis of product (drugs and devices), indication (GERD, dysphagia, achalasia, and burning chest pain), and end user (institutional sales and retail sales), across seven key regions.
For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/31550
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/ineffective-esophageal-motility-treatment-market.asp
Read More Trending "PMR Exclusive Article"-
Immunooncology Market@ https://www.persistencemarketresearch.com/market-research/immunooncology-market.asp
Pharmaceutical Excipients For Taste Masking Market@ https://www.persistencemarketresearch.com/market-research/pharmaceutical-excipients-for-taste-masking-market.asp
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Ineffective Esophageal Motility Treatment Market to keep pace with the latest technology here
News-ID: 2525763 • Views: …
More Releases from Persistence Market Research
Flavors in the OTC Pharmaceuticals Market to Grow from US$2.3 Bn in 2025 to US$3 …
The global flavors in over-the-counter (OTC) pharmaceuticals market is witnessing steady growth, reflecting a broader shift in consumer preference for palatable and user-friendly medications. Traditionally, OTC medications were associated with bitter or unpleasant tastes, which often led to poor adherence, particularly among pediatric and geriatric populations. With advancements in flavor technology and increased focus on patient compliance, pharmaceutical manufacturers are increasingly integrating a wide array of flavors into their products.…
Hydrating Drinks Market Size US$ 42.0 Bn in 2026 | Driven by Rising Health Aware …
The global hydrating drinks market is poised for significant expansion over the coming years, driven by increasing consumer awareness of health and wellness, rising fitness trends, and the demand for functional beverages. Market research estimates indicate that the market size is likely to be valued at US$ 42.0 billion in 2026 and is projected to reach US$ 58.5 billion by 2033, representing a compound annual growth rate (CAGR) of 5.0%…
Yerba Mate Market valued at US$2.1 Bn driven by health trends to reach US$3.0 Bn …
The global yerba mate market is demonstrating steady and resilient growth, driven by rising consumer awareness of natural functional beverages, expanding health and wellness trends, and increasing global penetration beyond its traditional South American stronghold. In 2026, the global yerba mate market size is likely to be valued at approximately US$ 2.1 billion, reflecting its established consumption base and growing acceptance across new demographics. Over the forecast period from 2026…
Coffee Beverages Market US$266.7 Bn by 2033 Driven by Cafes RTD Demand and Urban …
The global coffee beverages market continues to demonstrate robust expansion, driven by evolving consumer lifestyles, premiumization trends, and the increasing penetration of café culture across both developed and emerging economies. As of 2026, the global coffee beverages market size is likely to be valued at US$ 185.8 billion, reflecting the strong and consistent demand for coffee-based drinks across retail, foodservice, and ready-to-drink channels. Looking ahead, the market is projected to…
More Releases for Ineffective
Ineffective Esophageal Motility Treatment Market Poised for Expansion, Notes Per …
The global Ineffective Esophageal Motility (IEM) Treatment Market has entered a period of sustained growth, propelled by rising gastrointestinal disorders and increasing awareness of esophageal motility diseases. Valued at US$ 4.21 billion in 2023, the market is projected to nearly double and reach US$ 7.47 billion by 2033, expanding at a steady 5.9% CAGR. IEM, often associated with conditions such as gastroesophageal reflux disease (GERD), dysphagia, and hiatal hernia, is…
Terischwartz Associates Exposes the True Cost of Ineffective Meetings in Today's …
Image: https://www.abnewswire.com/upload/2025/07/3cd3e20ec6c36670720e5834999ed2ab.jpg
Executives across the country sit in boardrooms and virtual rooms alike, facing a steady stream of meetings that move agendas sideways, not forward. At the center of this epidemic lies a rarely acknowledged truth: most meetings lack a clear purpose, structure, or outcome. Despite their ubiquity, they remain one of the greatest hidden inefficiencies in modern business.
Evan Unger [https://www.terischwartzassociates.com/our-team/evan-unger/], managing partner at a national leadership consulting firm, studies this…
Steep learning curve and ineffective customer support keep AccountEdge second to …
Brandon, MB--May 25, 2023: AccountEdge helps small businesses establish inventory, billing, managing contacts, creating and tracking sales and purchases. It's compatible with both Mac and Windows operating systems. An on-premise and accounting management solution, it gives users the freedom to create an eCommerce platform where they can sell items online using Shopify, download orders directly to the account and synchronize the inventory items for selling. The banking tool gives…
Ineffective Esophageal Motility Treatment Market 2022 Global Market Analysis and …
Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated.
The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such…
The Ineffective Esophageal Motility Treatment Market to Adopt Digitization
The Ineffective Esophageal Motility Treatment Market is there to witness remarkable growth in the forecast period. The existing scenario implies the consumerization of healthcare. In other words, technology is relieving the hospital staff from providing an appropriate level of the care needed, that too, in a better way. Data-driven diagnosis has seen the light of the day in wake of habits and requirements of smartphone-oriented patients. This would be the…
IAS Questions MoH Push for Ineffective Vaccine
The Immunisation Awareness Society is raising concern about the inadequate level of information provided to the public regarding the whooping cough vaccine.
Auckland, New Zealand, April 11, 2012 -- GIVEN the current push by the Ministry of Health (MoH) for people to get their whooping cough (pertussis) vaccinations, the Immunisation Awareness Society (IAS) is raising concerns about the inadequate level of information provided around vaccination in New Zealand.
The latest figures from…
